This Week in NEJM | GenomeWeb

This Week in NEJM

Premium

In NEJM this week, researchers in Michigan, North Carolina, and Arizona identify germline mutations in HOXB13 that may increase a person's risk for prostate cancer. Family history has been shown to be a significant risk factor for prostate cancer, but its molecular basis has not yet been properly understood, the researchers write. In this study, the team screened more than 200 genes on chromosome 17q21-22 from germline DNA of 94 patients with familial prostate cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.